𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FK633: A Potent and Selective Platelet GPIIb/IIIa Antagonist

✍ Scribed by Aoki, Toshiaki ;Harada, Kayoko ;Seki, Jiro ;Tanaka, Akito ;Takasugi, Hisashi ;Motoyama, Yukio

Book ID
109105979
Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
91 KB
Volume
17
Category
Article
ISSN
0897-5957

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characterization of the anti-platelet ac
Characterization of the anti-platelet actions of FK419, a novel non-peptide antagonist of platelet GPIIb/IIIa
✍ Kayoko Mihara; Toshiaki Aoki; Akira Moriguchi; Hiroko Yamamoto; Masashi Maeda; N πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 169 KB

## Abstract The anti‐platelet properties of FK419 ((S)‐2‐acetylamino‐3‐[(R)‐[1‐[3‐(piperidin‐4‐yl)propionyl]piperidin‐3‐ylcarbonyl] amino]propionic acid), a novel non‐peptide GPIIb/IIIa antagonist, were compared in a variety of experimental settings, both in vitro and in vivo, with other GPIIb/IIIa

Orbofiban: An orally active GPIIb/IIIa p
Orbofiban: An orally active GPIIb/IIIa platelet receptor antagonist
✍ Nancy S. Nicholson; Norman A. Abood; Susan G. Panzer-Knodle; Leo G. Frederick; J πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 438 KB

## Abstract A key role has been established for platelet activation and thrombus formation in the pathogenesis of acute coronary syndromes, and restenosis after percutaneous interventions. Antiplatelet agents that have a wider spectrum of activity than aspirin, and clopidogrel would be expected to